FBXW7 and ovarian carcinoma: Recent research reports that the tumour suppressor FBW7 mediates YTHDF2 protein hydrolysis via ubiquitination to inhibit ovarian cancer proliferation and growth; In contrast, FBW7 inhibits BMF mRNA degradation in an m6A-YTHDF2 manner to support ovarian cancer apoptosis, which is a downstream target of YTHDF2 [40].